Pharmaceutical

Filter

Current filters:

None

Popular Filters

6710 to 6734 of 6948 results

PTC Therapeutics and Genzyme restructuring ataluren collaboration

04-09-2011

Privately-held PTC Therapeutics and fellow USA-based Genzyme, now part of French drug major Sanofi (Euronext:…

atalurenGenzymeLicensingPharmaceuticalPTC TherapeuticsRare diseasesSanofi

Japan’s Toyobo to increase capacity for injectables, eyeing biosimilars

04-09-2011

Japanese conglomerate Toyobo (TYOO: 3101) has outlined plans for its biosciences segment, which includes…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPharmaceuticalToyobo

French medical-imaging market worth 800 million euros

04-09-2011

Medical imaging is an extremely open and dynamic sector in France, thanks to government initiatives which…

EuropeMarkets & MarketingPharmaceutical

US FTC long-awaited final report finds brand-name firms use leverage of authorized generic entry to delay competition

02-09-2011

The USA’s Federal Trade Commission this week issued its final report, titled Authorized Generic…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Erbitux and Gilenya added to Australia’s PBS listing

02-09-2011

More than 400,000 Australians will benefit from new subsidized medicines, effective September 1, as Minister…

Asia-PacificErbituxGilenyaMerck KGaANeurologicalNovartisOncologyPharmaceuticalPricingRegulation

Roche’s Tarceva Oked in EU for first-line use in a genetically distinct type of lung cancer

02-09-2011

Swiss drug major Roche (ROG: SIX) says that the European Commission has approved Tarceva (erlotinib)…

EuropeOncologyPharmaceuticalRegulationRocheTarceva

Executive changes at Onyx Pharma and XOMA

02-09-2011

Onyx Pharmaceuticals (Nasdaq: ONXX) has appointed Helen Torley as executive vice president and chief…

ManagementOnyx PharmaceuticalsPharmaceuticalXOMA Corp

PCMA outlines $100 billion in Rx drug savings in USA

01-09-2011

As the USA’s Joint Select Committee on Deficit Reduction examines options to reduce the deficit…

BiotechnologyGenericsHealthcareNorth AmericaPharmaceuticalPricingRegulation

RUBY-1 trial shows Astellas’ blood thinner darexaban increases bleeding

01-09-2011

A Phase II dose-finding study has found that the new oral Factor Xa inhibitor darexaban, under development…

Astellas PharmaCardio-vasculardarexabanPharmaceuticalResearch

UCB presents new data on Vimpat and health care costs associated with epilepsy at IEC meeting

01-09-2011

Consistent evidence that adjunctive treatment with epilepsy drug Vimpat (lacosamide) was generally well…

HealthcareNeurologicalPharmaceuticalResearchUCBVimpat

Astellas files for OAB drug mirabegron in USA and Europe

01-09-2011

Japanese drug major Astellas Pharma (TYO: 4503) says it has submitted a New Drug Application and Market…

Astellas PharmaBetanisGastro-intestinalsmirabegronPharmaceuticalRegulation

Sinclair IS in Episil licensing deal with Teva

01-09-2011

UK-based specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) has signed a license agreement with Israel’s…

EpisilLicensingNeurologicalOncologyPharmaceuticalSinclair IS PharmaTeva Pharmaceutical Industries

Pfizer’s Pristiq sees private plan formulary access similar to Lilly’s Cymbalta

31-08-2011

In the USA, similar percentages of private health plan lives have formulary access to Pfizer’s (NYSE:…

CymbaltaEli LillyHealthcareNeurologicalNorth AmericaPfizerPharmaceuticalPricingPristiq

Long-term outlook and predictability key to successful medicines policy for Australia, conference told

31-08-2011

A predictable regulatory and reimbursement environment, and a long-term policy outlook are essential…

Asia-PacificPharmaceuticalPricingRegulationResearch

Limited growth forecast for Singapore pharmaceuticals industry by BMI

31-08-2011

Singapore is a low-risk pharmaceutical market, propped up by pro-business policies, well developed health…

Asia-PacificHealthcareMarkets & MarketingPharmaceutical

Valeant out-bids Paladin with C$76 million cash bid for Afexa

31-08-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has entered…

Afexa Life SciencesMergers & AcquisitionsPaladin LabsPharmaceuticalValeant Pharmaceuticals

Public Citizen petitions US FDA to amend generic drug labeling regulations in the wake of Mensing

31-08-2011

The US Food and Drug Administration should revise its regulations to allow generic drug manufacturers…

GenericsNorth AmericaPharmaceuticalRegulation

Eisai updates on epilepsy drugs Zonegran, Zebinix and perampanel at IEC

31-08-2011

Japanese drug major Eisai (TYO: 4523) presented new data at the International Epilepsy Congress taking…

BIALEisaieslicarbazepineNeurologicalperampanelPharmaceuticalResearchZebinixZonegran

US FDA stalls Novartis Ilaris approval for gouty arthritis, calling for more clinical data

31-08-2011

There was a big disappointment, albeit not unexpected, for Swiss drug major Novartis (NOVN: VX) when…

Anti-Arthritics/RheumaticsIlarisNorth AmericaNovartisPharmaceuticalRegulation

6710 to 6734 of 6948 results

Back to top